We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Noom Stock

Invest in or calculate the value of your shares in Noom or other pre-IPO companies through EquityZen's platform.

Get Started

Noom Stock (NOOM)

Digital Health Platform

Noom is a behavior change company that exists in the weight loss and healthcare industries.

About Noom Stock

Founded

2007

Headquarters

New York, NY, US

Total Funding

756M

Industries

Software, Artificial Intelligence, Data and Analytics

Noom is a behavior change company in the weight loss and healthcare industries. By combining the power of artificial intelligence, mobile tech, and psychology with over 1,000 personal coaches, Noom aims to help people live healthier lives by changing their long-term habits. Noom’s behavior change courses include its virtual diabetes prevention program, which the CDC has recognized. Noom claims its platform is used by healthcare and pharmaceutical companies to improve treatment outcomes for patients worldwide.

Noom was founded in 2007 by Saeju Jeong and Artem Petakov and is headquartered in New York City with offices in Seoul and Tokyo. Notable investors include Kleiner Perkins Caufield & Byers, Sequoia Capital, Silver Lake, and Samsung Ventures.

Noom Press Mentions

Stay in the know about the latest news on Noom

Investors in Noom

Discover investors in Noom stock and explore their portfolio companies

Noom Management

Leadership team at Noom

Chief Executive Officer

Saeju Jeong

Chief of Psychology

Andreas Michaelides

Locked Features

Join now and verify your accreditation status to gain access to:

  • Noom current valuation
  • Noom stock price
  • Available deals in Noom and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Noom Stock

How to invest in Noom stock?

Accredited investors can buy pre-IPO stock in companies like Noom through EquityZen funds. These investments are made available by existing Noom shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Noom stock?

Shareholders can sell their Noom stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."